Ventilation imaging study for asthma patients
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial uses special imaging to look at how air moves through your lungs. It may help doctors understand asthma better and could lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 75 years old.
- You have been diagnosed with asthma for at least 1 year, and your asthma started before age 40 or your lung function is between 50% and 80% of normal.
- Your asthma symptoms are not fully controlled with your current inhaler therapy.
- You have not had a severe asthma attack or needed emergency care or steroids in the last 3 months.
- You can use inhalers correctly and perform breathing tests while sitting and lying down.
- You are not pregnant or breastfeeding, and if you could become pregnant, you must use highly effective birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses advanced imaging to study the shape of airways in adults with asthma who have active symptoms and inflammation. It aims to find out if certain airway shapes affect how well treatments work, which could lead to more personalized asthma care.
This study tests a new combination inhaler (fluticasone propionate and albuterol) for people with asthma age 12 and older. It helps see if this inhaler works better than a placebo in controlling asthma symptoms and preventing attacks.
This study is for adults referred by their GP who may have asthma or were given an asthma diagnosis without proper testing. It aims to improve how asthma is diagnosed.
This study looks at how asthma affects air flow and blood flow in your lungs. You may join if you use daily asthma control medicine and your breathing test shows room for improvement even after using a rescue inhaler.
This trial studies new technologies to help doctors diagnose asthma and better understand airway inflammation. It may help you (or healthy volunteers, if eligible) by allowing your breathing tests and inflammation markers to be measured with newer diagnostic tools.
This trial tests whether stepping up to either a higher dose of inhaled steroid/long-acting bronchodilator or a special fine-particle triple therapy (which includes an extra medication) can improve small-airway health in people whose asthma is still not well controlled on a medium-dose combination.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.